- Home
- VET vs ATAI Comparison
VET vs ATAI Comparison
Compare VET & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VET | ATAI |
|---|---|---|
| Founded | 1994 | 2018 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 2004 | 2021 |
Fundamental Metrics
Financial Performance| Metric | VET | ATAI |
|---|---|---|
| Price | $11.30 | $3.42 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | $15.00 | ★ $15.29 |
| AVG Volume (30 Days) | 1.9M | ★ 4.1M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 3.29% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $308,000.00 |
| Revenue This Year | $10.98 | $955.84 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.14 | $1.15 |
| 52 Week High | $12.00 | $6.73 |
Technical Indicators
Market Signals| Indicator | VET | ATAI |
|---|---|---|
| Relative Strength Index (RSI) | 67.32 | 39.75 |
| Support Level | $7.18 | $1.29 |
| Resistance Level | N/A | $4.40 |
| Average True Range (ATR) | 0.48 | 0.28 |
| MACD | 0.04 | -0.05 |
| Stochastic Oscillator | 70.09 | 4.57 |
Price Performance
Historical ComparisonAbout VET Vermilion Energy Inc.
Vermilion Energy Inc is an international oil and gas-producing company. The company engages in full-cycle exploration and production programs that focus on the acquisition, exploration, development, and optimization of producing properties in North America, Europe, and Australia. The majority of Vermilion's revenue is derived from the production and sale of petroleum and natural gas. In each market, the company relies on a host of drilling and well-completion techniques to keep production at attractive levels. Geographically, the company derives majority of its revenue from Canada.
About ATAI ATAI Life Sciences N.V.
Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.